Yutaka Tamada

489 total citations
13 papers, 414 citations indexed

About

Yutaka Tamada is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Yutaka Tamada has authored 13 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Yutaka Tamada's work include Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yutaka Tamada is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yutaka Tamada collaborates with scholars based in Japan and United States. Yutaka Tamada's co-authors include Naoki Shinojima, Seiji Kondo, Takashi Shingu, Tomohisa Yokoyama, Oliver Bögler, Yasuhiko Akiyama, Keishi Fujiwara, Kouzo Moritake, Daisuke Aoki and Tatsuro Irimura and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Molecules.

In The Last Decade

Yutaka Tamada

13 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yutaka Tamada Japan	9	244	236	69	65	65	13	414
Hala Elnakat Thomas United States	9	312 1.3×	145 0.6×	45 0.7×	110 1.7×	27 0.4×	9	460
Núria Eritja Spain	6	209 0.9×	117 0.5×	26 0.4×	110 1.7×	50 0.8×	10	409
Ernest Medina United States	6	444 1.8×	160 0.7×	101 1.5×	80 1.2×	35 0.5×	9	607
ShuYun Zhang United States	5	252 1.0×	185 0.8×	306 4.4×	43 0.7×	42 0.6×	5	476
Tom Mikkelson United States	5	287 1.2×	312 1.3×	51 0.7×	122 1.9×	41 0.6×	6	530
Giorgia Pilotto Italy	10	397 1.6×	85 0.4×	31 0.4×	257 4.0×	55 0.8×	11	550
Chunxu Yang China	10	254 1.0×	88 0.4×	41 0.6×	104 1.6×	25 0.4×	15	356
Agata Mrowinska United Kingdom	2	351 1.4×	376 1.6×	71 1.0×	166 2.6×	59 0.9×	2	593
Antonio Lucena-Cacace Spain	14	365 1.5×	78 0.3×	33 0.5×	104 1.6×	47 0.7×	23	598
Manuela Hugle Germany	11	263 1.1×	66 0.3×	76 1.1×	41 0.6×	25 0.4×	14	365

Countries citing papers authored by Yutaka Tamada

Since Specialization

Citations

This map shows the geographic impact of Yutaka Tamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Tamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Tamada more than expected).

Fields of papers citing papers by Yutaka Tamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Tamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Tamada. The network helps show where Yutaka Tamada may publish in the future.

Co-authorship network of co-authors of Yutaka Tamada

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Tamada. A scholar is included among the top collaborators of Yutaka Tamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Tamada. Yutaka Tamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tamada, Yutaka, Hiroyuki Nomura, Daisuke Aoki, & Tatsuro Irimura. (2021). A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells. Molecules. 26(19). 5962–5962. 6 indexed citations

Takano, Masashi, Kazuya Kudoh, Tsunekazu Kita, et al.. (2015). Combination therapy with temsirolimus and trabectedin for recurrent clear cell carcinoma of the ovary: A phase II study with biomarker analysis.. Journal of Clinical Oncology. 33(15_suppl). 5583–5583. 5 indexed citations

Hisamatsu, Takeshi, Seiji Mabuchi, Tomoyuki Sasano, et al.. (2015). The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer. Clinical & Experimental Metastasis. 32(8). 789–798. 8 indexed citations

Tamada, Yutaka, Hideyuki Takeuchi, Nao Suzuki, Daisuke Aoki, & Tatsuro Irimura. (2012). Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells. Tumor Biology. 33(4). 1215–1222. 13 indexed citations

Tsuda, Hiromasa, Yutaka Tamada, Masahiro Yoshioka, et al.. (2009). Combination of Abducens Nerve Palsy and Ipsilateral Postganglionic Horner Syndrome as an Initial Manifestation of Uterine Cervical Cancer. Internal Medicine. 48(16). 1457–1460. 6 indexed citations

Shingu, Takashi, Keishi Fujiwara, Oliver Bögler, et al.. (2009). Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy. 5(4). 537–539. 34 indexed citations

Aoki, Hiroshi, Yasuko Kondo, Kenneth Aldape, et al.. (2008). Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy. 4(4). 467–475. 100 indexed citations

Shingu, Takashi, Keishi Fujiwara, Oliver Bögler, et al.. (2008). Inhibition of autophagy at a late stage enhances imatinib‐induced cytotoxicity in human malignant glioma cells. International Journal of Cancer. 124(5). 1060–1071. 148 indexed citations

Aoki, Daisuke, et al.. (2008). Establishment and Characterization of the RMG-V Cell Line from Human Ovarian Clear Cell Adenocarcinoma. Human Cell. 18(3). 143–146. 15 indexed citations

10.

Tamada, Yutaka, Hideyuki Takeuchi, Nao Suzuki, et al.. (2007). Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary. Cancer Science. 98(10). 1586–1591. 12 indexed citations

11.

Nomura, Hiroyuki, Yutaka Tamada, Taeko Miyagi, et al.. (2006). Expression of NEU3 (Plasma Membrane-Associated Sialidase) in Clear Cell Adenocarcinoma of the Ovary: Its Relationship With T Factor of pTNM Classification. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 16(6). 289–297. 40 indexed citations

12.

Suzuki, Nao, Daisuke Aoki, Yutaka Tamada, et al.. (2004). HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells. Gynecologic Oncology. 95(2). 290–298. 16 indexed citations

13.

Tamada, Yutaka, et al.. (1999). Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.. PubMed. 11(5). 233–41. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact